Indrayani Biotech Ltd Financials

Indrayani Biotech Ltd Financial Statement

Indrayani Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	10.40	11.82	19.25
Operating Expense	8.07	9.81	14.79
Net Profit	0.10	0.13	0.07
Net Profit Margin	0.96	1.10	0.36
Earning Per Share	0.02	0.03	0.08
EBIDTA	2.34	2.01	3.43
Effective Tax Rate	1.29	1.99	12.13

Particulars	Sep 2024
Revenue	10.40
Operating Expense	8.07
Net Profit	0.10
Net Profit Margin	0.96
Earning Per Share	0.02
EBIDTA	2.34
Effective Tax Rate	1.29

Indrayani Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	62.32	74.48	57.99
Operating Expenses Annual	56.66	65.83	51.76
Operating Profit Annual	9.28	8.80	6.45
Interest Annual	4.83	2.78	1.88
Depreciation	1.45	0.93	0.34
Net Profit Annual	1.46	5.06	4.23
Tax Annual	1.55	0.02	TBA

Particulars	Mar 2024
Total Revenue Annual	62.32
Operating Expenses Annual	56.66
Operating Profit Annual	9.28
Interest Annual	4.83
Depreciation	1.45
Net Profit Annual	1.46
Tax Annual	1.55

Indrayani Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.62	1.45	0.63
Cash Flow from Operations	26.09	8.33	3.47
Cash Flow from Investing	-7.26	-14.09	0.59
Cash Flow from Financing	-19.19	4.93	-3.23
Cash Flow at the End	0.26	0.62	1.45

Particulars	Mar 2024
Cash Flow at the Beginning	0.62
Cash Flow from Operations	26.09
Cash Flow from Investing	-7.26
Cash Flow from Financing	-19.19
Cash Flow at the End	0.26

Indrayani Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	15.12	11.90	11.14
PBIT Margin (%)	12.79	10.65	10.55
PBT Margin (%)	10.21	6.92	4.96
Net PROFIT Margin (%)	2.34	6.79	7.29
Return On Networth / Equity (%)	2.78	12.48	15.61
Return On Networth /Employed (%)	7.23	10.59	14.18
Return On Assets (%)	1.38	7.54	11.09
Total Debt / Equity (X)	1	0.79	0.73
Asset Turnover Ratio (%)	0.59	1.11	1.52

Particulars	Mar 2024
PBDIT Margin (%)	15.12
PBIT Margin (%)	12.79
PBT Margin (%)	10.21
Net PROFIT Margin (%)	2.34
Return On Networth / Equity (%)	2.78
Return On Networth /Employed (%)	7.23
Return On Assets (%)	1.38
Total Debt / Equity (X)	1
Asset Turnover Ratio (%)	0.59

Indrayani Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	21.66	23.81	15.33
Total Current Assets Annual	71.50	49.33	17.99
Non Current Assets Annual	54.50	50.97	31.44
Total Shareholders Funds Annual	54.52	51.15	24.18
Total Assets Annual	126.01	100.30	49.43

Particulars	Mar 2024
Fixed Assets Annual	21.66
Total Current Assets Annual	71.50
Non Current Assets Annual	54.50
Total Shareholders Funds Annual	54.52
Total Assets Annual	126.01

Indrayani Biotech Ltd Earning Calls

EPS (INR)

Expected

0.27

Reported

0.13

Surprise

-51.85%

Jun 2024

EPS beaten by -51.85%

Mar 2024

EPS beaten by -47.37%

Dec 2023

EPS beaten by -44.23%

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Indrayani Biotech Ltd has a market capitalization of 223.90 Cr. Value Research classifies it as a Small-Cap company.

No, Indrayani Biotech Ltd is not debt-free with a debt-to-equity ratio of 1.16.

In FY 2023 , Indrayani Biotech Ltd recorded a total revenue of approximately 62.32 Cr marking a significant milestone in the company's financial performance.

Indrayani Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.0% annually, respectively..

Indrayani Biotech Ltd's current PE ratio is 153.36.

Indrayani Biotech Ltd's ROCE averaged 10.0% from the FY ending March 2022 to 2024, with a median of 8.4%. It peaked at 14.9% in March 2022, reflecting strong capital efficiency over the period..

Indrayani Biotech Ltd's latest EBIT is Rs. 7.84 Cr, surpassing the average EBIT of Rs. 7.27 Cr over the 5 years..